Yüklüyor......
B7-H3/CD276: An Emerging Cancer Immunotherapy
Immunotherapy aiming at suppressing tumor development by relying on modifying or strengthening the immune system prevails among cancer treatments and points out a new direction for cancer therapy. B7 homolog 3 protein (B7-H3, also known as CD276), a newly identified immunoregulatory protein member o...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8326801/ https://ncbi.nlm.nih.gov/pubmed/34349762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.701006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|